Dysentery is a clinical condition of multiple origin. It could be bacillary or amoebic in nature. Dysentery is characterised by frequent discharge of blood stained, mucopurulent stools. Infection with this organism often leads to ulceration of the intestinal epithelium.
[ XLD- Xylose lysine deoxycholate agar
•
yeast
extract
•
sodium
chloride (NaCl)
•
xylose
•
lactose
•
sucrose
•
lysine
•
sodium thiosulfate
•
ferric ammonium citrate
•
phenol
red
•
sodium deoxycholate
•
agar
•
water
sodium deoxycholate as
the selective agent inhibitory to gram-positive micro-organisms.
Xylose is fermented by
practically all enterics except for the Shigella
Lysine -Salmonella would
ferment the xylose and exhaust the supply of xylose; then, lysine is attacked via the enzyme
lysine decarboxylase- creates alkaline pH – red colour (which mimics the Shigella reaction).
Sodium thiosulfate and ferric
ammonium citrate in the medium, helps in the visualization of the
hydrogen sulfide produced, resulting in the formation of colonies with
black centers- Salmonellae
Degradation of xylose, lactose and sucrose generates
acid products, causing a color change in the medium from red to yellow- E.
coli
Hydrogen sulfide production
under alkaline conditions causes colonies to develop black centers- Salmonellae
Lysine decarboxylation
causes reversion to an alkaline condition and the color of the medium
changes back to red- Salmonellae
Salmonella Typhi
– Red Colonies, Black Centers
Shigella sonnei – Red
Colonies
Shigella flexneri – Red
Colonies
Escherichia coli – Large, Flat, Yellow Colonies; some strains may be inhibited]
|
Sub group A |
Subgroup B |
Subgroup C |
Subgroup D |
|
Shigella dysenteriae |
Shigella
flexneri - Flexner from Philippines (1900). |
Shigella boydii -Boyd from India (1931) |
Shigella sonnei- Carl Olaf Sonne (1915) in Germany. |
|
Mannitol non-fermenting |
Mannitol
fermenting |
Mannitol
fermenting |
Ferment mannitol, also ferment lactose
and sucrose late |
|
12 serotypes |
six serotypes
(1-6) and several subtypes |
18 serotypes
have been identified. |
Shigella sonnei together
with Shigella flexneri- 90% of Shigellosis cases |
|
Type-1 forms Shiga toxin- exotoxin-
Neurotoxicity, enterotoxicity & cytotoxicity/verotoxin |
Usually treated
with antibiotics, although some strains have become resistant. |
Most
genetically divergent species of the genus Shigella |
Mildest form of bacillary dysentery. |
- Human beings are the only natural hosts
- Transmission through
•
Contaminated
water & food
•
Contaminated
fingers, flies, food/faeces, fomites (door handles, water taps, lavatory seats)
- Four “F” s
•
In
young male homosexuals, through gay bowel syndrome
•
Low
infective dose – as low as 100 Bacilli
Pathogenicity
of Shigella dysenteriae
•
Shigella cause disease by invading and
replicating in cells lining the colon.
•
Adhere
to the cells, invade, replicate intracellularly and spread cell-to-cell.
•
They
first attach to and invade the M cells located in Peyer patches
•
Shigella lyse the phagocytic vacuole
and replicate in the host cell cytoplasm- cause necrosis of epithelial cells –
superficial ulcers
- Cell-to-cell passage: The bacteria are propelled through the cytoplasm to adjacent cells, with the rearrangement of actin filaments in the host cells
- Shigella survive phagocytosis by inducing programmed cell death (apoptosis).
- This process releases IL-1β-
attracts polymorphonuclear leukocytes into the infected tissues.
- This destabilizes the
integrity of the intestinal wall and allows the bacteria to reach the
deeper epithelial cells.
S. dysenteriae strains
produce an exotoxin, Shiga similar to the verotoxin of E. coli O157:H7.
The toxin primarily
Ø damages
the intestinal epithelium;
Ø also
damage glomerular endothelial cells, resulting in renal failure (HUS)
The clinical features of Shigella dysenteriae type 1
infection includes:
1) toxemia, sometimes bacteremia and severe
dysentery leading to marked dehydration and protein loss
2) Inflammation and ulceration of the large intestine
3) Hemorrhage, abdominal pain and high fever
4) Death from circulatory collapse or kidney failure
Shigella can cause
v Shigellosis
v Other
complications
v Rectal prolapse
v Toxic
megacolon
v Hemolytic-uremic
syndrome (HUS)
Shigellosis is characterized by:
1)Abdominal cramps 2)Diarrhea 3)Fever 4)Bloody stools
5)The clinical symptoms of the disease appear 1 to 3
days after the bacteria are ingested. Lasts for 5-7 days, recovery maybe in two
weeks also (patient is contagious in this period).
6) The first sign of infection is
profuse watery diarrhea which is mediated
by an enterotoxin
7) Invasion of the colonic mucosa by the bacteria – result in lower abdominal cramps and tenesmus (straining
to defecate- feeling to defecate even if bowels are empty), with
abundant pus and blood in the stool.
8)Abundant neutrophils, erythrocytes, and mucus are
found in the stool.
9)Infection is generally self-limited, although
antibiotic treatment is recommended to reduce the risk of secondary spread to
family members and
other contacts.
10)Asymptomatic colonization of the organism in
the colon develops in a small number of patients – acts as a persistent
reservoir for infection.
Complications
of Shigellosis
In some cases, Shigellae also cause
inflammation of the lining of the rectum (proctitis) or rectal
prolapse.
In rare cases (more commonly in S.
dysenteriae infection), “toxic megacolon” -a deadly
complication - colon becomes paralyzed, preventing bowel movements - abdominal
pain and swelling, fever, weakness, and disorientation.
Untreated, the colon may rupture and cause peritonitis,
a life-threatening condition requiring emergency surgery.
Hemolytic
Uremic Syndrome (HUS)
1) Hemolytic-uremic syndrome (HUS) is a
group of blood disorders primarily in children, characterized by HUS triad -acute
kidney failure, destruction of red blood cells, and low platelets –
due to Shiga toxin
2)HUS can occur after S. dysenteriae type 1
infection.
3)Convulsions in children
4)It is usually complicated by severe dysentery, intravascular volume depletion, and
cardiovascular collapse; has a higher morbidity and mortality rate
than E. coli associated HUS
Shiga toxin enters the bloodstream and attacks endothelial cells throughout the body, damages the lining of small blood vessels and triggers tiny blood clots resulting in HUS triad
Ø Microangiopathic
Hemolytic Anemia: The destruction of red blood cells as they are forced
through damaged, narrowed vessels, leading to anemia and fatigue.
Ø Thrombocytopenia:
A low platelet count, as platelets are rapidly consumed trying to repair the
damaged vessel walls.
Ø Acute
Kidney Injury (AKI): Impaired kidney function (azotemia) caused by clots
clogging the small blood vessels in the kidneys.
Lab diagnosis
Sample
- Fresh stool sample
- Rectal swab
- Serum
- Gram negative, rods, along with pus cells and RBC's.
- Non-motile, non-capsulated, non-spore forming
MacConkey
agar: Non-lactose
fermenting (except S. sonnei), large, circular, convex, smooth, and
translucent.
Deoxycholate
citrate agar (DCA): Colorless
colonies , (non-lactose fermenting) except in the case of S. sonnei
which forms pink colonies due to late lactose fermentation.
Xylose
lysine deoxycholate (XLD) agar:
Colonies are red without black centers.
Salmonella-Shigella
(SS) agar: Colorless colonies with no blackening
Heaktoen
Enteric Agar (HEA):
Green to blue- green colonies.
MacConkey agar Deoxycholate citrate agar (DCA)
- Using monovalent and polyvalent anti-sera
- For serotyping- to know the strain and not for lab diagnosis
Treatment
- Uncomplicated Shigellosis – self-limiting – rest & rehydration must- no antibiotics for adults.
- For infants & children – oral rehydration to be ensured
- Perform antibiotic sensitivity test
- Fluoroquinolones such as ciprofloxacin or cotrimoxazole
- The treatment should be continued for 5-7 days.
� Postinfection
carriage is generally less than 3-4 weeks.
� Mild cramps and diarrhea may continue for many days to weeks after treatment of shigellosis.
PREVENTION
AND CONTROL
- No vaccine currently available.
- Personal & environmental hygiene
Prevention by
1) Use of safe drinking water
2) Chlorination of water source
3) Strict
handwashing
4) Refrigeration and proper preparation and cooking of
food
5) Food handlers must be treated with antibiotics and should not be involved in food preparation as long as stool cultures are positive for Shigella infection.